Pfizer

Pfizer   (Big pharma)
Formation	1849
Headquarters	New York City
Interest of	Ehden Biber, Tiffany Dover, Fazze, Owen Smith, Cristian Terheș, Vasudha Vats
Member of	Alliance for Biosecurity, Business Roundtable, Council on Foreign Relations/Corporate Members, Transatlantic Policy Network
Sponsored by	Bill & Melinda Gates Foundation
Exposed by	Michèle Rivasi
Subpage	•Pfizer/CEO •Pfizer/Vice President

Pfizer Inc. is a multinational pharmaceutical corporation. In 2012, it was one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Products

Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Its products include the blockbuster drug Lipitor (atorvastatin), used to lower Low-density lipoprotein (LDL) blood cholesterol; Lyrica (pregabalin) for neuropathic pain and fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex (also Celebra, celecoxib), an anti-inflammatory drug.

Mergers

In 2016, Pfizer was expected to merge with Allergan to create the Ireland-based "Pfizer plc" in a deal that would have been worth US$160 billion. The merger was called off in April 2016, however, because of new rules from the US Department of the Treasury against tax inversions, a method of avoiding taxes by merging with a foreign company. The company has made the second-largest pharmaceutical settlement with the United States Department of Justice.

On 19 December 2018, Pfizer announced a joint merger of their consumer healthcare division with UK pharma giant GlaxoSmithKline which maintains a controlling 68% of shares.

COVID-19 vaccine

On 9 November 2020, Pfizer and partner BioNTech announced that their vaccine against COVID-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement — and relief — in the face of the global pandemic.

Pfizer CEO Albert Bourla instantly cashed in on the announcement, selling 60 percent of his Pfizer stock at $41.99, its highest level in more than a year. The sale had been arranged in advance under a so-called Rule 10b5-1 trading plan, which allows corporate executives to make predetermined stock transactions in compliance with insider trading laws. Bourla adopted the trading plan in August of this year.

Also Sally Susman, the company’s executive vice president and chief corporate affairs officer, dumped more than 43,000 shares to the tune of about $1.8 million. The sale was similarly made under a Rule 10b5-1 plan Susman adopted in November 2019.

The vaccine was the first to be tested in the United States to generate late-stage data. The companies said an early analysis of the results showed that individuals who received two injections of the vaccine three weeks apart experienced more than 90% fewer cases of symptomatic Covid-19 than those who received a placebo. For months, researchers have cautioned that a vaccine that might only be 60% or 70% effective.

The Phase 3 study is ongoing and additional data could affect results.

In keeping with guidance from the Food and Drug Administration, the companies will not file for an emergency use authorisation to distribute the vaccine until they reach another milestone: when half of the patients in their study have been observed for any safety issues for at least two months following their second dose. Pfizer expects to cross that threshold in the third week of November:

“I’ve been in vaccine development for 35 years,” said William Gruber, Pfizer’s senior vice president of vaccine clinical research and development. “I’ve seen some really good things. This is extraordinary.” He later added: “This really bodes well for us being able to get a handle on the epidemic and get us out of this situation.”

 

An event carried out

Event	Location	Description
Foster child drug trials	New York US	National Institutes of Health and Big Pharma force fed experimental pharmaceuticals to infants, toddlers, children and teenagers in New York and elsewhere in the United States.

 

Related Quotations

Page	Quote	Author	Date
BioNTech	“Yes, I would love to get vaccinated too, we just have to see that we follow the legal basics. We will have to produce over 1.3 billion doses of vaccine in the next six months, it is important that there are no staff absences and accordingly we are thinking about finding ways that legally allow us to protect our staff as well. But we have, that is still in the clarification at the moment.”	Ugur Sahin	December 2020
COVID-19/Resistance	“I have done my bit and been vaccinated because we were told that was the route to protect others and regain our freedoms. Neither was correct. I will not allow my perfectly healthy body to become a cash cow for Pfizer.”	Allison Pearson	9 December 2021
Dominic Cummings	“In March [2020] I started getting calls from various people saying these new mRNA vaccines could well smash the conventional wisdom. [. . .] People like Bill Gates and that kind of network were saying. [. . .] Essentially what happened is, [. . .] there is a network of people, Bill Gates type people, who were saying completely rethink the paradigm of how you do this.. What Bill Gates and people like that were saying to me and others in number 10 was you need to think of this much more like the classic programs of the past. [. . .] the Manhattan Project in WWII, the Apollo program.. But what Bill Gates and people were saying [. . .] was, the actual expected return on this is so high that even if does turn out to be all wasted billions it's still a good gamble [. . .] and that is what we did.”	Dominic Cummings	May 2021

 

Employees on Wikispooks

Employee	Job	Appointed	End	Description
Hans Groth	Senior Director for Healthcare Policy & Market Access	1988	2012	Attended 2011 Bilderberg.
Owen Smith	Head of Policy and Government Relations	2005	2010

 

Sponsor

Event	Description
Bill & Melinda Gates Foundation	Very influential and rich foundation established to take leadership of global health.

 

Related Document

Title	Type	Publication date	Author(s)	Description
Document:Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial	article	2 November 2021	Paul D Thacker	Whistleblowers from a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial say never experienced such a “helter skelter" work environment, saying speed may have come at the cost of data integrity and patient safety.

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.